Skip to main content

Advertisement

Figure 5 | BMC Immunology

Figure 5

From: Synthesized OVA323-339MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells

Figure 5

FCM detection of CD4+CD25+Foxp3+Treg cells in peripheral blood, mediastinal draining lymph nodes, and spleen of mice. In vivo OVA challenge could decrease the level of Treg cells in the mice. However, the levels of local and peripheral CD4+CD25+Foxp3+ Treg cells was about 0.5-1.0-fold increase after OVA323-339MAP treatment (gating on CD4+ T cell populations, * compared with the control group, P < 0.05; # compared with the OVA group, P < 0.05). Data represent one of three independent experiments.

Back to article page